medtech
(109)
Johnson & Johnson left the medicine cabinet.
The name still evokes baby shampoo. The business now runs on cancer medicines, heart pumps and surgical technology. Its reinvention reveals the expensive work of turning scientific progress into everyday care.
BD and the power of small things
A syringe, a cabinet, a few centimeters of tubing. BD built a business around the details of care. Its next bet is that those details can talk to one another.
AdvaMed: The invention after the invention
A medical device can work perfectly and still struggle to reach a patient. AdvaMed organizes the companies trying to get through the other half of innovation: rules, reimbursement, and the politics of access.
Dash Technologies and the last mile of medicine
A medical device can do its job and still leave a hospital waiting. Dash Technologies builds the software that gets the result where it needs to go.
Definitive Healthcare maps the people behind the purchase
A hospital directory tells you where to knock. Definitive Healthcare tries to tell you whose door matters - and whether the trip is worth it.
Switzerland Innovation Park Basel Area sells scientists a head start
A biotech company can lose months before its first experiment. In the Basel Area, shared labs and room to grow turn the landlord into part of the research strategy.
Next4 Group wants to build the business before it writes the cheque
The Italian innovation holding has bought a venture builder and an AI specialist. Its bet: making a company ready for customers is part of making it ready for capital.
NEXT MANNHEIM knows what a startup needs next: a neighbour
A city-owned network gives founders specialised rooms, useful introductions and a route into industry. Its most revealing decision was to put a GreenTech ambition into a building it already had.
NEMIC helps medical ideas survive the expensive middle
A good medical idea can arrive years before a fundable business. In Providence, NEMIC works on the awkward interval between the two.
MatchPlay Wants Your Second Investor Meeting to Start Further Ahead
A pitch deck opens a conversation. MatchPlay is building a business around what comes next: checked facts, useful introductions, and a clearer route to capital.
Stratus Medical and the art of hitting a tiny nerve
A small expandable electrode is the centre of Stratus Medical’s chronic-pain business. Its story turns on a larger treatment zone, familiar equipment, and the surprisingly powerful role of an insurance policy.
Ajax Health builds the business around the breakthrough
A clever medical device still needs a route into the hospital. Ajax Health pairs small invention teams with big commercial engines - and makes the machinery of innovation its business.
The CRM That Followed the Patient Past the Sale
Servis.ai began as FreeAgent CRM. Its more interesting bet now is that healthcare's hardest work happens after a lead becomes a patient: referrals, visits, staffing, supplies, and the handoffs between them.
Gilmartin Group and the business of being believed
A healthcare breakthrough needs an investor who understands it. Gilmartin Group works on the awkward space between a company’s evidence, its promises, and the people writing the checks.
Accelpoint gets startups into the room where pilots happen
The Warsaw accelerator pairs public funding with corporate access. Its real test is whether a promising prototype can become something a bank, insurer or telecom will actually use.
DERBI Foundation and the hard part after the prototype
A medical device can work on a lab bench and still struggle to reach a hospital. Bengaluru’s DERBI Foundation helps founders tackle the testing, clinical connections and commercial decisions in between.
Global HealthX wants your startup to survive the hospital
A surgeon’s venture studio is tackling the awkward stretch between a promising healthcare product and a hospital that will actually use it. Its India market programme even makes room for a useful answer: no.
SmiLe gives biotech founders a lab - and lets them keep their equity
At Sweden’s SmiLe Venture Hub, shared laboratories come with business coaches, industry introductions and a patient timetable. The proposition is practical: spend less effort assembling the infrastructure, and more proving the business.
BOM is betting on fewer doors between an idea and a business
The Dutch public investor pairs venture capital with hands-on company building and international connections. Its latest move tackles a problem closer to home: a startup support system with too many moving parts.
At Dalhousie’s ideaHUB, the next business starts on a workbench
Hardware founders need somewhere to build, test and change their minds. Inside Dalhousie’s Emera ideaHUB, shared labs and engineering advice help turn promising research into physical products.
Lyonbiopôle works on biotech’s other problem: who opens the next door?
A promising discovery still needs partners, money and a route to patients. Lyonbiopôle has spent two decades organizing those introductions - and its new strategy puts the business end of science under the microscope.
H7 BioCapital starts with the buyer
The healthcare investor puts licensing and acquisition demand near the start of the startup journey. Its accelerator, angel syndicate and conference circuit turn that thesis into introductions, coaching and deal-by-deal investment.
The Rice-Sized Sensor Trying to End the IVF Blood-Test Marathon
A fertility patient can give blood every other day for weeks and still miss the hormone surges that decide whether a cycle works. Impli wants to put a continuous read of that biology under the skin - or on it.
The Sisters Who Bet a Healthcare Ad Agency Could Run Without an Office - and Sold It in Ten Years
Barbara Pantuso and Lisa Reid started a remote healthcare agency before remote was cool, sold complex science as clear stories, and cashed out to Supreme Group ten years later. Here is how they did it - and what a small shop can steal from the playbook.
Orange Biomed Bet Its A1C Test on One Weird Fact: Sugar Makes Blood Cells Stiff
A Duke-born startup turned the stiffness of red blood cells into a pocket-size diabetes test. The science is clever; the harder experiment is getting a regulated device from a five-minute demo into millions of homes.
Philips Bet the Whole Company on Hospitals - Then a CPAP Recall Almost Broke It
It made light bulbs, then TVs, then the CT scanner in your local hospital. The story of how a Dutch electronics giant reinvented itself as a pure health-tech company - and nearly lost the bet.
The AI that reads every medical paper so pharma's scientists don't have to
Medical teams at drug companies read maybe 10% of the evidence that matters. Sorcero built AI agents to read the other 90% - and about a third of the top 30 global pharma companies are now paying for it.
The Startup Teaching Ventilator Patients to Breathe on Their Own Again
Every long stint on a ventilator quietly weakens the one muscle you need to breathe. XN Health's Phlex device stimulates the phrenic nerve through the breathing tube to keep the diaphragm working - and get patients off the machine sooner.
The Doctors Are Writing the Checks
Global Health Impact Network & Funds has built a venture firm around a simple correction: let clinicians judge healthcare technology before the market does. Its network supplies the expertise, the diligence and, increasingly, the capital.
The Venture Fund With an Admissions Requirement: You Had to Go to Oxford
A Palo Alto fund turned an alumni network into an asset class - if your startup wants in, someone in the founding story has to have walked through an Oxford quad.